These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 36273372)

  • 1. Algebra, Geometry and Topology of ERK Kinetics.
    Marsh L; Dufresne E; Byrne HM; Harrington HA
    Bull Math Biol; 2022 Oct; 84(12):137. PubMed ID: 36273372
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Investigating dynamics of inhibitory and feedback loops in ERK signalling using power-law models.
    Vera J; Rath O; Balsa-Canto E; Banga JR; Kolch W; Wolkenhauer O
    Mol Biosyst; 2010 Nov; 6(11):2174-91. PubMed ID: 20717620
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Paclitaxel induces prolonged activation of the Ras/MEK/ERK pathway independently of activating the programmed cell death machinery.
    Okano J ; Rustgi AK
    J Biol Chem; 2001 Jun; 276(22):19555-64. PubMed ID: 11278851
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Importance of MEK-1/-2 signaling in monocytic and granulocytic differentiation of myeloid cell lines.
    Miranda MB; McGuire TF; Johnson DE
    Leukemia; 2002 Apr; 16(4):683-92. PubMed ID: 11960350
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interferon-alpha2b reduces phosphorylation and activity of MEK and ERK through a Ras/Raf-independent mechanism.
    Romerio F; Riva A; Zella D
    Br J Cancer; 2000 Aug; 83(4):532-8. PubMed ID: 10945503
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Algebraic Systems Biology: A Case Study for the Wnt Pathway.
    Gross E; Harrington HA; Rosen Z; Sturmfels B
    Bull Math Biol; 2016 Jan; 78(1):21-51. PubMed ID: 26645985
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Insights into erlotinib action in pancreatic cancer cells using a combined experimental and mathematical approach.
    Lange F; Rateitschak K; Kossow C; Wolkenhauer O; Jaster R
    World J Gastroenterol; 2012 Nov; 18(43):6226-34. PubMed ID: 23180942
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Superoxide anion-dependent Raf/MEK/ERK activation by peroxisome proliferator activated receptor gamma agonists 15-deoxy-delta(12,14)-prostaglandin J(2), ciglitazone, and GW1929.
    Huang WC; Chio CC; Chi KH; Wu HM; Lin WW
    Exp Cell Res; 2002 Jul; 277(2):192-200. PubMed ID: 12083801
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MEK/ERK-mediated proliferation is negatively regulated by P38 map kinase in the human pancreatic cancer cell line, PANC-1.
    Ding XZ; Adrian TE
    Biochem Biophys Res Commun; 2001 Mar; 282(2):447-53. PubMed ID: 11401480
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PI3K/Akt-sensitive MEK-independent compensatory circuit of ERK activation in ER-positive PI3K-mutant T47D breast cancer cells.
    Aksamitiene E; Kholodenko BN; Kolch W; Hoek JB; Kiyatkin A
    Cell Signal; 2010 Sep; 22(9):1369-78. PubMed ID: 20471474
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantifying ERK activity in response to inhibition of the BRAFV600E-MEK-ERK cascade using mathematical modelling.
    Hamis SJ; Kapelyukh Y; McLaren A; Henderson CJ; Roland Wolf C; Chaplain MAJ
    Br J Cancer; 2021 Nov; 125(11):1552-1560. PubMed ID: 34621046
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MEK-ERK pathway is expressed but not activated in high proliferating, self-renewing cord blood hematopoietic progenitors.
    Bonati A; Lunghi P; Gammaitoni L; Pinelli S; Ridolo E; Dall'Aglio PP; Piacibello W; Aglietta M
    Hematol J; 2002; 3(2):105-13. PubMed ID: 12032872
    [TBL] [Abstract][Full Text] [Related]  

  • 13. RAF inhibitors transactivate RAF dimers and ERK signalling in cells with wild-type BRAF.
    Poulikakos PI; Zhang C; Bollag G; Shokat KM; Rosen N
    Nature; 2010 Mar; 464(7287):427-30. PubMed ID: 20179705
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Opposed effects of lithium on the MEK-ERK pathway in neural cells: inhibition in astrocytes and stimulation in neurons by GSK3 independent mechanisms.
    Pardo R; Andreolotti AG; Ramos B; Picatoste F; Claro E
    J Neurochem; 2003 Oct; 87(2):417-26. PubMed ID: 14511119
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of a novel mitogen-activated protein kinase kinase activation domain recognized by the inhibitor PD 184352.
    Delaney AM; Printen JA; Chen H; Fauman EB; Dudley DT
    Mol Cell Biol; 2002 Nov; 22(21):7593-602. PubMed ID: 12370306
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sensitivity analysis predicts that the ERK-pMEK interaction regulates ERK nuclear translocation.
    Radhakrishnan K; Edwards JS; Lidke DS; Jovin TM; Wilson BS; Oliver JM
    IET Syst Biol; 2009 Sep; 3(5):329-41. PubMed ID: 21028924
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cross-talk between JNK/SAPK and ERK/MAPK pathways: sustained activation of JNK blocks ERK activation by mitogenic factors.
    Shen YH; Godlewski J; Zhu J; Sathyanarayana P; Leaner V; Birrer MJ; Rana A; Tzivion G
    J Biol Chem; 2003 Jul; 278(29):26715-21. PubMed ID: 12738796
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PPP6C negatively regulates oncogenic ERK signaling through dephosphorylation of MEK.
    Cho E; Lou HJ; Kuruvilla L; Calderwood DA; Turk BE
    Cell Rep; 2021 Mar; 34(13):108928. PubMed ID: 33789117
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Robustness of MEK-ERK Dynamics and Origins of Cell-to-Cell Variability in MAPK Signaling.
    Filippi S; Barnes CP; Kirk PD; Kudo T; Kunida K; McMahon SS; Tsuchiya T; Wada T; Kuroda S; Stumpf MP
    Cell Rep; 2016 Jun; 15(11):2524-35. PubMed ID: 27264188
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inference of Multisite Phosphorylation Rate Constants and Their Modulation by Pathogenic Mutations.
    Yeung E; McFann S; Marsh L; Dufresne E; Filippi S; Harrington HA; Shvartsman SY; Wühr M
    Curr Biol; 2020 Mar; 30(5):877-882.e6. PubMed ID: 32059766
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.